Since NF-kB is a mediator of immune response [40], the ING4/NF-kB axis is likely to elicit tumor-immune modulation resulting in a TIME that may contribute to disease progression, but the immune composition in ING4-deficient tumors has not been characterized to date. The gene discussed is NFKB1; the disease is neoplasm.